Superior Prima Sukses Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Superior Prima Sukses Tbk. trades at Rp140 (market cap 1.25T, 591.3K 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B, 12.18M 24h volume). The key difference: Superior Prima Sukses Tbk. is far larger — about 7.8× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (12.18M versus 591.3K). Which is the better fit depends on your goals.
| BLES | DKHH | |
|---|---|---|
Market Cap | 1.25T | 160.67B |
Volume | 591.3K | 12.18M |
Lot | 5.91K | 121.83K |
Turnover | 83.24M | 762.52M |
Average Price | 140.77 | 62.59 |
Value | 83.24M | 762.52M |
Indicative Equilibrium Price | 140 | 63 |
Indicative Equilibrium Volume | 408 | 2.19K |
Trailing returns across standard periods
Latest headlines on both assets
PT Superior Prima Sukses Tbk (the Company) was established based on Notarial Deed of Sriwati, S.H., M.Hum., No. 8 dated November 3, 2011. The Company started its operations in April 2013. PT Global Base Universal is the ultimate parent entity of the Company.
Read more on BLES →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →